The Alcohol Research Center on HIV (ARCH) is a multidisciplinary program project grant focused on reducing the impact of alcohol on the breadth and depth of the HIV epidemic. Funded by NIAAA in September of 2010, the ARCH comprises 3 major research components in addition to an Administrative Core and a Research Methods Core.

The Center for Addiction and Disease Risk Exacerbation's (CADRE) mission is to become a national leader in substance use bio-behavioral research and chronic disease manifestations in vulnerable populations (especially underrepresented ethnic or racial minorities), serving as a resource for training and research within Brown University as well as regionally and nationally.

Technology transfer begins during the development of a new technology, continues through its dissemination, and extends into its early implementation. This process requires multiple stakeholders and resources, and involves activities related to translation and adoption. Technology transfer is designed to accelerate the diffusion of an innovation.

The South Africa HIV ATTC is a United States President's Emergency Plan for AIDS Relief (PEPFAR) and Substance Abuse and Mental Health Services Administration (SAMHSA) funded centre dedicated to providing training and technical assistance to providers addressing substance use, mental health and HIV throughout the country.

In 2018, an estimated 34.2 million American adults were current cigarette smokers, with 74.6 percent of people who smoke using tobacco daily (CDC, 2019). While this number has decreased over recent decades, the ways in which youths and adults intake nicotine continues to change as the products available to them change.

We study the causes and consequences of alcohol use in young adults, as well as the subjective evaluation of alcohol-related consequences in young adults.

We coalesce preclinical and human laboratory models to examine stress-related biobehavioral mechanisms in addiction medicine. Our current work focuses on the noradrenergic system, stress-associated peptides and the hypothalamic-pituitary-adrenal (HPA) axis.

Project MIMIC (Maximizing Implementation of Motivational Incentives in Clinics) is an implementation trial funded by the National Institute on Drug Abuse (NIDA). Project MIMIC is partnering with 30 community-based opioid treatment centers across New England to implement contingency management. Contingency management is a treatment approach that provides patients with motivational incentives for complying with treatment.